| Acetaminophen | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Acetaminophen | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
| Acetaminophen | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | |
| Acetaminophen | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Acetaminophen | hsa03013 | RNA transport | 3.98E-02 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
| Acetaminophen | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | |
| Acetaminophen | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | |
| Acetaminophen | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | |
| Acetaminophen | hsa04071 | Sphingolipid signaling pathway | 1.87E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | |
| Acetaminophen | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P38571, Q13510, P07602, P61916, Q04900, Q9Y227 | HEXA, LIPA, ASAH1, PSAP, NPC2, CD164, ENTPD4 | More | |
| Acetaminophen | hsa04144 | Endocytosis | 1.38E-03 | 10 | P0DMV8, Q9H444, O75351, P62491, P42566, Q15438, Q14161, Q96QK1, Q9UMY4, Q9UNH7 | HSPA1A, CHMP4B, VPS4B, RAB11A, EPS15, PSCD1, GIT2, VPS35, SNX12, SNX6 | More | |
| Acetaminophen | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | |
| Acetaminophen | hsa04217 | Necroptosis | 3.99E-02 | 6 | P23458, Q9NQC7, P01584, Q9BTM1, Q9H444, O75351 | JAK1, CYLD, IL1B, H2AFJ, CHMP4B, VPS4B | More | |
| Acetaminophen | hsa04260 | Cardiac muscle contraction | 4.78E-02 | 3 | P67936, P13073, P12074 | TPM4, COX4I1, COX6A1 | More | |
| Acetaminophen | hsa04270 | Vascular smooth muscle contraction | 2.89E-02 | 2 | P35579, P35318 | MYH9, ADM | More | |
| Acetaminophen | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
| Acetaminophen | hsa04613 | Neutrophil extracellular trap formation | 7.32E-03 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | |
| Acetaminophen | hsa04640 | Hematopoietic cell lineage | 1.64E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
| Acetaminophen | hsa04657 | IL-17 signaling pathway | 4.98E-02 | 6 | O00463, Q16539, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, MMP9, ANAPC5, LCN2, TNF | More | |
| Acetaminophen | hsa04658 | Th1 and Th2 cell differentiation | 1.85E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
| Acetaminophen | hsa04659 | Th17 cell differentiation | 1.64E-03 | 2 | P20036, P04234 | HLA-DPA1, CD3D | More | |
| Acetaminophen | hsa04664 | Fc epsilon RI signaling pathway | 7.22E-03 | 2 | Q9UQC2, P20292 | GAB2, ALOX5AP | More | |
| Acetaminophen | hsa04672 | Intestinal immune network for IgA production | 3.16E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Acetaminophen | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.93E-02 | 1 | Q9Y5S1 | TRPV2 | More | |
| Acetaminophen | hsa04940 | Type I diabetes mellitus | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Acetaminophen | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | |
| Acetaminophen | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Acetaminophen | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Acetaminophen | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | |
| Acetaminophen | hsa05034 | Alcoholism | 3.30E-02 | 2 | Q96RR4, P84243 | CAMKK2, H3F3A | More | |
| Acetaminophen | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | |
| Acetaminophen | hsa05134 | Legionellosis | 2.82E-02 | 3 | P01584, Q9NR31, P0DMV8 | IL1B, SAR1A, HSPA1A | More | |
| Acetaminophen | hsa05142 | Chagas disease | 4.93E-02 | 1 | P04234 | CD3D | More | |
| Acetaminophen | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Acetaminophen | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Acetaminophen | hsa05166 | Human T-cell leukemia virus 1 infection | 9.87E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
| Acetaminophen | hsa05169 | Epstein-Barr virus infection | 3.43E-03 | 2 | P20036, P04234 | HLA-DPA1, CD3D | More | |
| Acetaminophen | hsa05202 | Transcriptional misregulation in cancer | 1.45E-02 | 12 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, BMI1, MPO, ELA2, GADD45A | More | |
| Acetaminophen | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.93E-02 | 1 | P04234 | CD3D | More | |
| Acetaminophen | hsa05310 | Asthma | 2.71E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Acetaminophen | hsa05320 | Autoimmune thyroid disease | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Acetaminophen | hsa05321 | Inflammatory bowel disease | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Acetaminophen | hsa05330 | Allograft rejection | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Acetaminophen | hsa05332 | Graft-versus-host disease | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Acetaminophen | hsa05340 | Primary immunodeficiency | 1.81E-02 | 1 | P04234 | CD3D | More | |
| Acetaminophen | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
| Acetaminophen | hsa05416 | Viral myocarditis | 4.49E-02 | 1 | P20036 | HLA-DPA1 | More | |
